Illumina’s shares are somewhat volatile and ... Today’s young investors likely haven’t read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written ...

Cathie Wood says most profound application of AI is in healthcare. She particularly expects Recursion Pharma and Illumina to ...

Shares of genomics company Illumina (NASDAQ:ILMN) fell 8.6% in the morning session after the company reported fourth-quarter results and provided full-year revenue guidance, which fell below Wall ...

The Federal Trade Commission's recent challenge to Microsoft's acquisition of Activision has been rejected by a federal court ...

Genomics company Pacific Biosciences of California (NASDAQ:PACB) will be announcing earnings results tomorrow after market ...

What Happened? Shares of genomics company Illumina (NASDAQ:ILMN) fell 6.3% in the afternoon session after China put the company on its "unreliable entity" list, opening the door to possible sanctions.

China’s Ministry of Commerce announced Tuesday it was implementing counter tariffs against the U.S. on multiple products.

The new exco didn’t turn up for the Wednesday meeting that was attended by the president of the Uganda Rugby Union Godwin ...

Genomics is bringing in a new wave of money from an unlikely group of investors — health systems. More providers are ...

After implementing 25% tariffs on North American trading partners, Donald Trump suspended them two days later and raised the ...